Overview

Study of SkQ1 as Treatment for Dry-eye Syndrome

Status:
Completed

Trial end date:
2019-02-09

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate whether SkQ1 ophthalmic solutions are safe and effective compared to placebo for the treatment of the signs and symptoms of dry eye syndrome.

Phase:

Phase 3

Details

Lead Sponsor:

Mitotech, SA

Collaborator:

ORA, Inc.

Treatments:

Ophthalmic Solutions
Pharmaceutical Solutions